Multicenter Randomized Controlled Clinical Trial Comparing Ebastine and Mebeverine as Treatment of Irritable Bowel Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05815602

Title field or adapter rule

{'original_value': 'Multicenter Randomized Controlled Clinical Trial Comparing Ebastine and Mebeverine as Treatment of Irritable Bowel Syndrome', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:34.863229+00:00

Published At

2026-09-11T00:00:00+00:00

Record Updated At

2026-09-11

Source Retrieved At

2026-10-31T22:18:48.933435+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["IBS - Irritable Bowel Syndrome", "IBS"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-09-11", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT05815602"

protocolSection.identificationModule.officialTitle

"Multicenter Randomized Controlled Clinical Trial Comparing Ebastine and Mebeverine as Treatment of Irritable Bowel Syndrome"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• IBS - Irritable Bowel Syndrome (protocolSection.conditionsModule.conditions)
• IBS (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Ebastine verum and duspatalin placebo'], 'description': 'Randomized subjects will administer 4 pills of study medication per day during 12 weeks.\n\nDaily administration schedule consists of taking 2 pills in the morning (1 verum, and 1 placebo). In the evening, subjects will take a second dose of both verum and placebo.', 'name': 'Ebastine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Duspatalin verum and ebastine placebo'], 'description': 'Randomized subjects will administer 4 pills of study medication per day during 12 weeks.\n\nDaily administration schedule consists of taking 2 pills in the morning (1 verum, and 1 placebo). In the evening, subjects will take a second dose of both verum and placebo.', 'name': 'Duspatalin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Ebastine (protocolSection.armsInterventionsModule.interventions[].name)
• Duspatalin (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.